The AstraZeneca vaccine was banned again for three months

Resume

[La vacuna AstraZeneca ha sido prohibida nuevamente durante tres meses, y el euro es demasiado largo para llorar]German Health Minister Jens Spahn and state government officials have agreed to vaccinate only people 60 and over, unless the vaccinated person is infected. at high risk of new coronary pneumonia and voluntarily vaccinated. Spahn said: “In summary, this is a trade-off between the risk of side effects and the risk of contracting a new coronary pneumonia. Although the proportion of such side effects is very low, it must be taken seriously” (Huitong.com)

German Health Minister Jens Spahn and state government officials agreed,Only vaccinate people 60 years of age and older, unless the vaccinated person is a high-risk group for new coronary pneumonia and is voluntarily vaccinated.Spahn said: “In summary, this is a trade-off between the risk of side effects and the risk of developing a new coronary pneumonia. Although the proportion of such side effects is very low, it must be taken seriously.”

Germany found 31 rare cases of thrombosis, again restricting vaccination

The Paul Ehrlich Institute in Germany, a federal agency and medical regulatory agency, stated:The agency has received 31 cases of cerebral venous thrombosis. Among them, 19 cases reported thrombocytopenia. Nine people have died in these cases. According to the research institute, of the 31 cases, with two exceptions, the rest were women between 20 and 63 years old, and the two men were 36 and 57 years old.The institute stated that it will continue to investigate and evaluate all newly received case reports and actively participate in relevant discussions with the European Medicines Agency (EMA). Data shows that as of Monday, nearly 2.7 million people in Germany have received the first dose of the AstraZeneca vaccine and 767 people have received the second dose of the vaccine.

Germany’s move is sure to put more pressure on AstraZeneca and also leave the public confused and concerned about vaccines. Earlier this month, before the EMA and the World Health Organization reviewed the vaccine’s safety data and concluded that it was “safe and effective” and had more advantages than disadvantages, AstraZeneca had discontinued a vaccine in some countries. Europeans.

However, the EMA said at the time that a connection between injection and thrombosis cannot be ruled out, and there is also a certain proportion of thrombosis in the general population. On Monday, Canada also suspended use of the vaccine for people under the age of 55 due to concerns that the vaccine may be linked to blood clots.

International agency defends AstraZeneca

Many scientists and the British government have defended this vaccine, saying that it has saved thousands of lives. AstraZeneca said in a statement that international regulators have found that the benefits of its injections far outweigh any possible risks. The company said it continues to analyze the tens of millions of vaccine records in its database to understand whether “the proportion of rare cases related to thrombocytopenia in the vaccinated population is higher than the general population.” Continue to work with the German authorities to resolve any issues that may arise “

AstraZeneca said: “Regulatory agencies in the UK, the European Union and the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus far outweigh the risks in all adult populations.” . He added: “The monthly safety update released by the EMA today reiterated the benefit risk profile of the vaccine.”

　　Clinical and real-world data show that the vaccine can significantly reduce new cases of coronary pneumonia, hospitalizations, and deaths. This vaccine is an important part of the immunization program in the UK and other countries, and is considered a low-cost vaccine that is easy to transport and store.

This month, Emer Cooke, executive director of the European Medicines Agency (EMA), said the agency had reached “clear scientific conclusions”, adding: “This is a safe and effective vaccine.” He said the research team did not find that the vaccine causes blood clots, although it cannot be ruled out with certainty that the vaccine is linked to a rare blood clotting disorder. Cooke added that the benefits of vaccines outweigh the risks, and the EMA and WHO have already emphasized this message.

The French epidemic may be increasing and the European epidemic raises concerns

Last week, German Health Minister Span said on Friday that cases are growing too fast and that the variant of the virus is a dangerous factor in this trend. According to the Swedish health agency RKI, the number of people who tested positive among 100,000 people in the last seven days has almost doubled in the last month to 119.1 people. Span said:“If this situation continues out of control, we will face the danger that the medical system will reach its limits in April.”

The situation in France seems worse. As of last week, nearly 4,700 people have received intensive care, and this number is approaching the peak of 4,900 in the fall of last year. The incidence of new coronary pneumonia is 325 cases per 100,000 population, almost three times that of Germany. According to two people familiar with the matter,French President Macron is likely to announce national measures on Wednesday night to curb the rise in new coronavirus infections. These measures can include school closings, intercity travel bans, etc.

With vaccination blocked and the influence of the third wave of the expanded epidemic, the economic outlook for the euro zone has raised concerns in the market. On Wednesday, the euro rose slightly against the dollar after hitting a fresh low of 1.1704 in more than four months.

(Source: Huitong.com)

(Editor-in-charge: DF520)